African Health Ministers Approve Roadmap For Medicines Access, Framework To End Cholera 03/09/2018 by Catherine Saez, Intellectual Property Watch 1 Comment Health ministers from the World Health Organization Africa region last week endorsed a roadmap for access for the years 2019-2023 concerning areas such as fair pricing, intellectual property management, and supply chain management. The previous day, they pledged to implement key strategies to end cholera outbreaks in the African region by 2030.
Negotiators On UN TB Resolution May Have A Deal 23/08/2018 by William New and David Branigan, Intellectual Property Watch 23 Comments NEW YORK – Negotiators for a United Nations declaration on tuberculosis, meeting intensively in New York this week, may have reached agreement today on a key sticking point related to intellectual property, innovation and access to new medicines, according to sources. An agreement, if accepted by other delegations, could allow the text to proceed to the high-profile High-Level Meeting scheduled to take place at the UN General Assembly next month.
Special Report: CBD Advisory Bodies Make Recommendations On Sequence Data, Global Mechanism, Implementation 02/08/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The UN Convention on Biological Diversity advisory bodies met last month to consider issues in preparation of the high-level Conference of the Parties later this year in Egypt. Among the topics were how to deal with genetic resources DNA information under the CBD protocol on access and benefit-sharing (Nagoya Protocol). Another was concerns met by countries implementing the protocol, in particular developing countries, and the need for capacity building.
Negotiations On UN Tuberculosis Declaration Still Open, Reports Say 27/07/2018 by William New, Intellectual Property Watch 2 Comments Negotiations for a United Nations declaration on ending tuberculosis had drawn to a close earlier this week, with the United States seeming to succeed on a hardline position to keep mention of intellectual property rights and affordability of medicines out of the text. But nongovernmental reports say the draft has not been accepted by all members and that negotiations will have to be reopened.
UN Political Declaration On TB Finalised: No Commitment To TRIPS Flexibilities 24/07/2018 by David Branigan, Intellectual Property Watch 3 Comments Members of the United Nations concluded negotiations on the draft of the Political Declaration on the Fight Against Tuberculosis on 20 July. After weeks of heated negotiations over the inclusion of references to TRIPS flexibilities in the operative paragraphs, with the Group of 77 pushing for inclusion and the United States against it, the final text of the political declaration reflects the deadlock of these positions. Due to the inability of member states to reach agreement, the final text does not include substantive reference to TRIPS flexibilities. If no countries object, this final draft of the Political Declaration on TB will be adopted by the General Assembly at the High-Level Meeting on Tuberculosis, which will take place on 26 September at the United Nations in New York, and will serve as the authoritative agreement from which action plans will be drawn. According to sources, countries have until tonight in New York to decide whether to object, and G77 nations are considering their options.
NGOs: Countries Pressured To Drop Reference To Affordable Medicines In UN TB Negotiations 20/07/2018 by William New, Intellectual Property Watch 2 Comments United Nations members in the final days of negotiating the text of the declaration for a late September high-level meeting on tuberculosis have come under pressure from the United States to omit language referring to the importance of making affordable medicines available to patients in need, according to an urgent bulletin today from a health advocacy group.
Monopolies: State And Corporate Interests Surrounding Access To Medicines 10/07/2018 by Adithi Koushik for Intellectual Property Watch Leave a Comment Amongst the many issues faced by developing countries to ensure access to medicines, cost is a primary one. Proposals to tackle it include limiting the price and regulating competitive conditions. Monopolies created by patents are seen by many as an impediment to accessing basic healthcare. Meanwhile, countries have realised that imposing stringent criteria for granting patents and taking a long duration to process them could be detrimental to them as much as resisting the regime.
UN Urged To Emphasize Health Over Profit At Upcoming UN High-Level Meeting On NCDs 06/07/2018 by David Branigan, Intellectual Property Watch 2 Comments An open letter sent by 242 organisations and individuals to key United Nations and World Health Organization representatives on 4 July demanded that high prices limiting access to medicines and effective treatment be addressed at the upcoming UN High-Level Meeting on Non-Communicable Diseases.
Health Policy Watch: Senior Reporter – Global Health Policy – Job Announcement 11/06/2018 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment NOTE: POSITION CLOSED – Health Policy Watch, www.healthpolicy-watch.org, is seeking a dynamic journalist to lead our reporting on global health policy issues in Geneva and beyond. The writer will form part of a small, dynamic team committed to providing top-quality, independent, professional reporting to our audience.
Experts In Geneva: Substandard, Falsified Medicines Not About IP 06/06/2018 by Catherine Saez, Intellectual Property Watch 1 Comment Falsified and substandard medical products continue to be a global concern, and how those products are characterised is important to avoid confusion, particularly with intellectual property rights infringement. A panel convened by Brazil, India and South Africa yesterday at the World Trade Organization looked at the implications of a new definition of such products at the neighbouring World Health Organization.